Norbert Schmitz

10PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).

Olivier Tournilhac, Bettina Altmann, Birte Friedrichs

|Aug 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.

Fabian Frontzek, Loïc Renaud, Ulrich Dührsen

|Mar 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial.

Michael Oertel, Marita Ziepert, Fabian Frontzek

|May 08, 2023
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.

Philipp Berning, Norbert Schmitz, Maud Ngoya

|Mar 16, 2020
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Frank Kroschinsky, Jan Moritz Middeke, Martin Janz

Pageof 2

Frequent Collaborators

3 joint publications

Eva Wagner-Drouet

3 joint publications

Peter Dreger

2 joint publications

Philipp Berning

2 joint publications

Ron Ram